We innovating and transform ideas into solutions that improve everyday life
Crystal Lake, IL
- Tweets 1,759
- Following 398
- Followers 1,207
- Likes 226
Aptar Pharma and Macquarie University collaborate on a three-year ARC-supported research program to advance inhaled biologic therapies using Aptar Pharma's Orbital™ dry powder inhaler platform. Read full Press Release: ow.ly/rQT350ZRnIc #Biologics #AptarPharma
33
What if the future of nasal drug delivery is defined not only by functionality, but by patient experience? Join Aptar Pharma's talk at #CPHIMilan on Oct. 7 to explore the evolution of patient-centric nasal drug delivery. #AptarPharma #NasalDrugDelivery
23
How can system-level performance data inform risk-based qualification for sterile injectables? #AptarPharma's article discusses worst-case scenario testing & the importance of evaluating vial stoppers as part of the complete Container Closure System ow.ly/r73a50ZQy1u
32
The nose-to-brain (N2B) conversation is evolving. As human imaging studies advance, the focus is shifting toward delivery performance, reproducibility and development confidence. Read #AptarPharma's latest published article to learn more: ow.ly/Sjeg50ZQe1K #DrugDelivery
30
Preservative-free. Multidose. One dispenser. Aptar Pharma's #OphthalmicSqueezeDispenser (OSD) combines patented Tip-Seal technology, a metal-free fluid path and documented microbiological integrity to support a wide range of ophthalmic applications. #AptarPharma #EyeCare #PFMD
64
EU GMP #Annex1 raised the bar, but what has changed in practice? In this interview, #AptarPharma's injectables experts discuss how Contamination Control Strategy shapes daily manufacturing & its impact on customers' #injectable products. Full interview: ow.ly/zMRI50ZO9w9
43
Aptar Pharma and Massachusetts General Hospital announce research collaboration to advance predictive, data-driven models for #NoseToBrain #DrugDelivery and support future CNS pipelines. Learn more: ow.ly/baWl50ZNzAv #AptarPharma
1
1
47
Aptar Pharma expands #PreservativeFree Technology production in Latin America with successful transfer of its APF production line to Berazategui, Argentina; strengthening local manufacturing & bringing #drugdelivery solutions closer to LATAM customers. ow.ly/AEaH50ZMwKR
74
What if you could know more about your syringe system - earlier? Our joint study with @StevanatoGroup evaluated PFS components together through a USP <382>-aligned, system-level approach. Read the findings in our publication: ow.ly/69jf50ZMqyV #USP382 #PrefilledSyringes
43
Today, Gael Touya, Aptar’s President and CEO, presented at the @WellsFargo Healthcare Conference, highlighting priorities that will allow Aptar to continue to deliver long-term value for stakeholders. To listen to the session, please visit our website: ow.ly/NpO350ZLEI8
57
Aptar Pharma announces collaboration with Aceso Therapeutics to advance ACT-101, an inhaled antisense oligonucleotide candidate for cystic fibrosis. Nanopharm, an Aptar Pharma company, will support formulation development & device assessment. ow.ly/rRG150ZKlpk
74
Join Aptar Pharma Services, Nanopharm and Gateway Analytical at Booth 11A43, Hall 11 at #CPHIMilan 2026. Learn about our end-to-end support from formulation and analytical expertise to regulatory support and clinical trial services. See you there! #DrugDevelopment
34
The future of drug delivery is being shaped by biologics, nucleic acids & new delivery strategies. Looking forward to the scientific discussions at #ParmaDD2026, where Aptar Pharma experts Philip Kuehl & Lucas Silva will be speaking.
#DrugDelivery #Inhalation #NasalDelivery
46
Protecting formulation integrity while enhancing the user experience. #AptarPharma #APFPlus features Top Seal technology designed to help protect sensitive formulations, reduce nozzle clogging & support preservative-free applications. ow.ly/pCzF50ZC7HB
42
Join #AptarPharma, Gold Sponsor at IPAC-RS Nasal Innovation Forum 2026, September 16-17. Our experts from #AptarPharma & #Nanopharm will share perspectives on translating innovation into clinical reality & advancing next generation nasal therapies. See you there! #DrugDelivery
30
We are pleased to officially welcome Gael Touya as President and CEO of #Aptar, and as a member of our Board of Directors. We look forward to the future with Gael’s #leadership and advancing our purpose: Innovating to transform ideas into solutions that improve everyday life.
1
3
59
One month to #CPHIMilan 2026 October 6-8! Meet our #AptarPharma team at Booth 11A43, Hall 11, alongside #AptarActiveMaterial Science, #Nanopharm, #GatewayAnalytical & #AptarDigitalHealth to learn how we can support your next #drugdelivery project, from formulation to patient.
54
Trusted in over 600 commercialized eye care products worldwide, Aptar Pharma's Ophthalmic Squeeze Dispenser (OSD) helps support preservative-free ophthalmic delivery with a proven platform backed by extensive data & expertise. Learn more: #EyeCare #AptarPharma #PreservativeFree
37
Aptar Pharma has received ISCC PLUS certification for our 5th manufacturing site, expanding our certified mass balance approach across five European sites. Through #Futurity®, we're helping consumer health brands move away from fossil/petroleum-based plastics. #Sustainability
35